113 related articles for article (PubMed ID: 33636974)
1. Clinicopathological, Immunohistochemical, and
Mousavi M; Goodarzi MT; Kassaee SM; Jafari Heidarloo A; Fathi M
Arch Iran Med; 2021 Feb; 24(2):86-93. PubMed ID: 33636974
[TBL] [Abstract][Full Text] [Related]
2. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
4. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
Zakout YM; Lanza G
J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of resectable colorectal cancer with mismatch repair protein defects in Chinese population: Retrospective case series and literature review.
Li J; Xu Q; Luo C; Chen L; Ying J
Medicine (Baltimore); 2020 Jun; 99(24):e20554. PubMed ID: 32541478
[TBL] [Abstract][Full Text] [Related]
6. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
[No Abstract] [Full Text] [Related]
7. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins.
Molaei M; Mansoori BK; Ghiasi S; Khatami F; Attarian H; Zali M
Int J Colorectal Dis; 2010 Jan; 25(1):63-9. PubMed ID: 19707776
[TBL] [Abstract][Full Text] [Related]
9. Colorectal carcinoma in Malaysians: DNA mismatch repair pattern in a multiethnic population.
Cheah PL; Looi LM; Teoh KH; Rahman NA; Wong LX; Tan SY
Asian Pac J Cancer Prev; 2014; 15(7):3287-91. PubMed ID: 24815484
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?
Shia J; Stadler Z; Weiser MR; Rentz M; Gonen M; Tang LH; Vakiani E; Katabi N; Xiong X; Markowitz AJ; Shike M; Guillem J; Klimstra DS
Am J Surg Pathol; 2011 Mar; 35(3):447-54. PubMed ID: 21297438
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
13. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
[No Abstract] [Full Text] [Related]
14. Immunohistochemical Analysis of Mismatch Repair Gene Proteins in Early Gastric Cancer Based on Microsatellite Status.
Sugimoto R; Endo M; Osakabe M; Toya Y; Yanagawa N; Matsumoto T; Sugai T
Digestion; 2021; 102(5):691-700. PubMed ID: 33053554
[TBL] [Abstract][Full Text] [Related]
15. Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.
Vlahović I; Rajc J; Švagelj I; Šolić K; Švagelj D
Pathol Oncol Res; 2023; 29():1610908. PubMed ID: 37325467
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
17. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry.
Zeng Z; Yan Q; Chen G; Zhang X; Huang J; Fu K; Peng X; Xiao S
Eur J Cancer Prev; 2021 May; 30(3):251-257. PubMed ID: 32826709
[TBL] [Abstract][Full Text] [Related]
20. Loss of DNA mismatch repair proteins in prostate cancer.
Sharma M; Yang Z; Miyamoto H
Medicine (Baltimore); 2020 May; 99(19):e20124. PubMed ID: 32384491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
